Biotech Investors & VC Firms
2107 firms in this list, with a median first check of $500K. 405 of them lead rounds. Generated from verified public data and updated continuously.
Decheng Capital
Menlo ParkSeed–Growth
16 people
Abingworth
LondonPre-Seed–Late Stage$15M – $30M
39 people
Ahren Innovation Capital
Cambridge, CambridgeshirePre-Seed–Late Stage
30 people
Jumpstart Ventures
ClevelandPre-Seed–Series A$500K – $2M
5 people
Agent Capital
WalthamPre-Seed–Late Stage
22 people
SOSV
New YorkPre-Seed–Series B$30K – $550K
29 people
DRI Healthcare
Toronto$7.3M – $36.5M
40 people
Mission Biocapital
San FranciscoPre-Seed–Series A$500K
21 people
Fortune Venture Capital
ShenzhenSeed–Late Stage$425K – $73M
11 people
UntroD Capital
TokyoPre-Seed–Growth$772K – $241M
5 people
Avoro Capital Advisors
New YorkSeed–Series A
22 people
Medicxi
LondonPre-Seed–Late Stage
34 people
ARCHIMED Japan
LyonGrowth–Late Stage$10.8M – $1.1B
22 people
S32
Palo AltoSeries A–Late Stage
25 people
Verve Ventures
ZugSeed–Series B$1.1M – $2.2M
9 people
The Column Group
San FranciscoPre-Seed–Late Stage$30M
26 people
Swanlaab Venture Factory
MadridSeed–Growth$540K – $3.2M
25 people
Cerity Partners Ventures
New YorkSeed–Late Stage
6 people
Ireland Strategic Investment Fund
DublinGrowth–Late Stage
37 people
Bee Partners
LafayettePre-Seed–Seed$300K – $500K
9 people
Linear Capital
ShanghaiPre-Seed–Series A$1M – $10M
18 people
Everywhere Ventures
New YorkPre-Seed–Seed$250K
7 people
Nina Capital
BarcelonaPre-Seed–Series A$215K – $1.6M
21 people
2048 Ventures
New YorkPre-Seed–Seed$500K – $3M
11 people
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.










































































